Enhancing Drug Safety with AI and Automation Technologies – with Marie Flanagan of IQVIA
Generative AI has been accelerating transformation across the life sciences, leaving pharmaceutical companies and clinical research organizations facing a dual challenge: modernizing pharmacovigilance while maintaining uncompromising standards for patient safety, data integrity, and global regulatory compliance. This delicate balance is most critical in adverse event detection and signaling, where a single missed risk can trigger…
